Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$12.0MFederal grants as PI15 awards
0Patents grantedNone matched
21Papers614 citations
Federal awards and patents by year
AwardsPatents
15 awards · $12.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 10, 2026 | NIH | SBIR Phase II Development of a topical tracer to detect TDP43 in ALS, LATE and FTD retinas for AI-powered disease insights | $1.1M | Amydis Diagnostics Inc. |
| Sep 9, 2025 | NIH | SBIR Phase II Development of a topical tracer to detect TDP43 in ALS, LATE and FTD retinas for AI-powered disease insights | $1.4M | Amydis Diagnostics Inc. |
| Aug 20, 2022 | NIH | SBIR Phase II Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics | $900K | Amydis Diagnostics Inc. |
| Aug 15, 2022 | NIH | SBIR Phase I Development of a novel fluorescent tracer for detection of retinal TDP43 in ALS and FTD | $459K | Amydis Diagnostics Inc. |
| Aug 12, 2022 | NIH | SBIR Phase I Development of a novel fluorescent tracer for detection of retinal TDP43 in ALS and FTD | $459K | Amydis Diagnostics Inc. |
| Sep 22, 2021 | NIH | SBIR Phase II Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics | $2.1M | Amydis Diagnostics Inc. |
| Aug 26, 2021 | NIH | SBIR Phase I Development of Novel Tau Retinal Tracers for Alzheimer's Disease and other Tauopathies | $492K | Amydis Diagnostics Inc. |
| Jun 5, 2020 | NIH | SBIR Phase II Development of a novel ophthalmic probe for cerebral amyloid angiopathy | $1.0M | Amydis Diagnostics Inc. |
| Sep 19, 2019 | NIH | SBIR Phase II Development of a novel ophthalmic probe for cerebral amyloid angiopathy | $490K | Amydis Diagnostics Inc. |
| Sep 30, 2018 | NIH | SBIR Phase I Development of Novel Prion Disease Diagnostic | $408K | Amydis Diagnostics Inc. |
| Sep 17, 2018 | NIH | SBIR Phase I Development of Novel Prion Disease Diagnostic | $408K | Amydis Diagnostics Inc. |
| Sep 10, 2017 | NIH | SBIR Phase I Development of a Novel Diagnostic Probe for Cerebral Amyloid Angiopathy | $535K | Amydis Diagnostics Inc. |
| Jul 10, 2017 | NIH | SBIR Phase II Development of an ophthalmic diagnostic probe for neurodegenerativedisorders | $211K | Amydis Diagnostics Inc. |
| Sep 23, 2016 | NIH | SBIR Phase II Development of an ophthalmic diagnostic probe for neurodegenerativedisorders | $1.6M | Amydis Diagnostics Inc. |
| Sep 18, 2015 | NIH | SBIR Phase I Development of an ophthalmic diagnostic probe for neurodegenerative disorders | $384K | Amydis Diagnostics Inc. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#47
Awards as PI#54
Patents#505
Companies
- Amydis Diagnostics Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.